Advancing Equity in Precision Oncology: Insights from Real-World Genomic Testing Trends in Metastatic Prostate Cancer

As precision medicine continues to reshape cancer care, ensuring equitable access to genomic testing remains a critical priority. New research presented at...

June 01, 2026 | Monday | Interaction
ILC Dover Expands Life Sciences Capabilities with New WFI Manufacturing and Custom Chemical Solutions Services

WFI manufacturing and other capabilities support for pharmaceutical innovation, GLP‑1 therapies, and medical devices. ILC Dover, an Ingersoll Rand bus...

May 28, 2026 | Thursday | News
Ginkgo Bioworks Launches ADME-One™ Integrated ADME Platform for AI-Driven Drug Discovery

Ginkgo Bioworks announced that its Datapoints offering is launching ADME-One™, a fully integrated ADME platform for drug discovery teams co-de...

May 28, 2026 | Thursday | News
Acurex Biosciences Awarded ASAP Grant to Advance Novel Parkinson’s Disease Therapeutic Research

Award funds collaboration with leading Parkinson’s researcher, Dr. Tim Greenamyre, to investigate a novel therapeutic approach for Parkinson&rsqu...

May 28, 2026 | Thursday | News
Eli Lilly and Company Reports Phase 3 TRIUMPH-1 Trial Shows Up to 30.3% Weight Loss with Retatrutide in Obesity

 In TRIUMPH-1, participants on 12 mg retatrutide lost an average of 70.3 lbs (28.3%) over 80 weeks with 45.3% of participants achieving ≥30% weig...

May 26, 2026 | Tuesday | News
HDT Bio Receives MCDC Innovation Prototype Award for Advancing HDT-321 CCHF Vaccine into Phase 1 Clinical Trials

HDT Bio, a clinical-stage biotechnology company based in Seattle, Washington,announced that it received the Medical CBRN Defense Consortium (MCDC) Innova...

May 26, 2026 | Tuesday | News
Assembly Biosciences Expands ABI-6250 Development Into Cholestatic Liver Diseases PBC and PSC

Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral diseases, today announced p...

May 25, 2026 | Monday | News
United Immunity Acquires Carisma Therapeutics Assets to Advance In Vivo CAR-M Therapies for Solid Tumors and Fibrosis

 United Immunity, Co., Ltd., a biotechnology company developing its proprietary Myeloid Targeting Platform™ for therapeutic in vivo engineerin...

May 22, 2026 | Friday | News
Cytiva Launches Next-Generation Biacore 8 Series Systems to Accelerate Drug Discovery Workflows

New Biacore 8S and Biacore 8S+ systems combine rapid screening and high-quality molecular characterization in a single system Biacore Insight So...

May 22, 2026 | Friday | News
Myosin Therapeutics Doses First Patient in Phase 1/2 STAR-GBM Trial for Novel Glioblastoma Therapy MT-125

Myosin Therapeutics, a clinical stage biotechnology company developing innovative therapies for oncology, announced that the first patient has been dosed...

May 21, 2026 | Thursday | News
ProtaGene and Merck KGaA Partner to Deliver End-to-End Biopharmaceutical Testing Solutions

ProtaGene announced a strategic partnership with the Life Science business of Merck, which operates as MilliporeSigma in the United States and Canada, to...

May 21, 2026 | Thursday | News
Lupin Receives U.S. FDA Tentative Approval for Generic Revefenacin Inhalation Solution

Global pharmaceutical leader Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN)  announced that it has received...

May 20, 2026 | Wednesday | News
Sanofi’s Phase 2 ElevAATe Data Show Efdoralprin Alfa Superior to Standard Augmentation Therapy in AATD

ATS: phase 2 data demonstrate the superiority of efdoralprin alfa over a standard-of-care augmentation therapy in achieving higher fAAT levels in AATD ...

May 20, 2026 | Wednesday | News
LOTTE Biologics Expands Strategic Collaboration with Ottimo Pharma to Advance OTP-01 Toward Commercialization

LOTTE Biologics (Co-CEOs James Park and Yooyeol Shin) announce an expansion of its collaboration with Ottimo Pharma, an innovative biotech company develo...

May 19, 2026 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close